IXICO plc (LON:IXI – Get Free Report) traded up 2.5% during mid-day trading on Tuesday . The company traded as high as GBX 11.45 ($0.14) and last traded at GBX 10.25 ($0.13). 162,444 shares traded hands during mid-day trading, an increase of 134% from the average session volume of 69,528 shares. The stock had previously closed at GBX 10 ($0.13).
IXICO Stock Up 2.2 %
The stock has a market cap of £5.56 million, a PE ratio of -287.50, a P/E/G ratio of -0.38 and a beta of 0.86. The business has a 50 day moving average of GBX 9.25 and a 200-day moving average of GBX 8.17. The company has a current ratio of 3.64, a quick ratio of 4.90 and a debt-to-equity ratio of 3.22.
Insider Activity
In other IXICO news, insider Mark Warne bought 26,370 shares of IXICO stock in a transaction dated Thursday, October 10th. The stock was acquired at an average cost of GBX 9 ($0.11) per share, with a total value of £2,373.30 ($3,003.04). Corporate insiders own 30.28% of the company’s stock.
About IXICO
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
Featured Articles
- Five stocks we like better than IXICO
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Trading Halts Explained
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.